Table 1.
Prohormone | ST1 | Hot Water |
---|---|---|
Cerebellin-1 | X | X |
Chromogranin-A | X | |
Cocaine- and amphetamine-regulated transcript protein | X | X |
Corticoliberin | X | X |
Neuroendocrine protein 7B2 | X | |
Neuropeptide S | X | |
Neurosecretory protein VGF | X | X |
Neurotensin/neuromedin N | X | |
Pituitary adenylate cyclase-activating polypeptide | X | X |
Proenkephalin-A | X | X |
Proenkephalin-B | X | |
Progonadoliberin-1 | X | X |
Secretogranin-1 | X | X |
Pro-MCH | X | X |
ProSAAS | X | X |
Protachykinin-1 | X | X |
Prothyroliberin | X | X |
Secretogranin-2 | X | X |
Secretogranin-3 | X | X |
Somatostatin | X | X |
Tachykinin-3 | X | |
Vasopressin-neurophysin 2-copeptin | X |
Prohormones detected in analyte extracts of different biological replicates (N=3) for each of the sample treatment procedures were combined, with peptide duplicates removed. A prohormone was considered only if it had at least one unique full-length peptide sequence; full length is defined as a peptide that is flanked by known basic cleavage sites in the prohormone.